Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by an abnormal function of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the phagocytic cells, which results in an increased susceptibility to severe bacterial and fungal infections. We report on a 12-year-old boy with X-linked CGD who was successfully treated with allogeneic bone marrow transplantation from an HLA-identical sibling following a conditioning regimen consisting of busulphan (BU, 16 mg/kg) and cyclophosphamide (CY, 200 mg/kg). At >2 years from transplant, the boy is in excellent clinical and hematological condition with full chimerism. Our patient is the 24th case of CGD transplanted from an HLA-identical sibling. A review of the literature revealed that 20 of 24 CGD patients are alive and disease free 1-7 years after transplant. Most of these patients were conditioned with the BUCY combination, which should be considered the recommended regimen.

Del Giudice, I., Iori, A., Mengarelli, A., Testi, A., Romano, A., Cerretti, R., et al. (2003). Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. ANNALS OF HEMATOLOGY, 82(3), 189-192 [10.1007/s00277-002-0590-0].

Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature

ROMANO, ANDREA;ARCESE, WILLIAM
2003-03-01

Abstract

Chronic granulomatous disease (CGD) is a rare primary immunodeficiency caused by an abnormal function of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the phagocytic cells, which results in an increased susceptibility to severe bacterial and fungal infections. We report on a 12-year-old boy with X-linked CGD who was successfully treated with allogeneic bone marrow transplantation from an HLA-identical sibling following a conditioning regimen consisting of busulphan (BU, 16 mg/kg) and cyclophosphamide (CY, 200 mg/kg). At >2 years from transplant, the boy is in excellent clinical and hematological condition with full chimerism. Our patient is the 24th case of CGD transplanted from an HLA-identical sibling. A review of the literature revealed that 20 of 24 CGD patients are alive and disease free 1-7 years after transplant. Most of these patients were conditioned with the BUCY combination, which should be considered the recommended regimen.
mar-2003
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/15 - MALATTIE DEL SANGUE
English
Con Impact Factor ISI
Genetic Linkage; Transplantation Conditioning; Humans; Chromosomes, Human, X; Child; Transplantation, Homologous; Cyclophosphamide; Tissue Donors; Histocompatibility Testing; Busulfan; Granulomatous Disease, Chronic; Treatment Outcome; Siblings; Bone Marrow Transplantation; Male
Del Giudice, I., Iori, A., Mengarelli, A., Testi, A., Romano, A., Cerretti, R., et al. (2003). Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. ANNALS OF HEMATOLOGY, 82(3), 189-192 [10.1007/s00277-002-0590-0].
Del Giudice, I; Iori, A; Mengarelli, A; Testi, A; Romano, A; Cerretti, R; Macrì, F; Iacobini, M; Arcese, W
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/68673
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 18
social impact